{"id":"W2565606062","doi":"10.1182/blood.v110.11.734.734","title":"Efficacy of Dasatinib in Patients with Chronic-Phase Chronic Myelogenous Leukemia with Resistance or Intolerance to Imatinib: 2-Year Follow-Up Data from START-C (CA180-013).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Imatinib; Medicine; Chronic myelogenous leukemia; Internal medicine; Imatinib mesylate; Gastroenterology; Pharmacology; Oncology; Leukemia; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001639368,0.0004846321,0.0009203666,0.0006594069,0.0005765365,0.000875235,0.0003874691,0.0006567727,0.0007483988],"category_scores_gemma":[0.001476829,0.0002198553,0.000951823,0.000768118,0.0004020653,0.0006066412,0.0003554298,0.0008329683,0.0003699636],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000772606,"about_ca_system_score_gemma":0.0004445905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002772247,"about_ca_topic_score_gemma":0.003104498,"domain_scores_codex":[0.9992602,0.0001767723,0.00009606271,0.0001697383,0.0001704734,0.0001268167],"domain_scores_gemma":[0.9980497,0.0003431397,0.0006888864,0.0001876658,0.0002434364,0.0004871791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02023929,0.0008153548,0.9597009,0.00007088628,0.0007580926,0.0006725195,0.0002259858,0.0003947446,0.003180525,0.00002462117,0.0006334182,0.01328368],"study_design_scores_gemma":[0.001364402,0.005220417,0.9895432,0.00001608357,0.0004037264,0.0008019508,0.0001051283,0.0004545359,0.0008595536,0.00002588521,0.001185086,0.00002003741],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980046,0.0008489342,0.00005988366,0.00003739071,0.000006189459,0.00003210701,0.0006365139,0.000004748697,0.0003696152],"genre_scores_gemma":[0.9972538,0.0002077591,0.00006984503,0.00005096111,0.00001945885,0.00002676766,0.002164111,0.000002057917,0.0002051515],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002772247,"threshold_uncertainty_score":0.008669913,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02252274156858766,"score_gpt":0.2861795180592287,"score_spread":0.2636567764906411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}